Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis. (2021)
Attributed to:
Driving innovation in precision medicine through translational life sciences research at the University of Leicester
funded by
UKRI
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2021.679388
PubMed Identifier: 34712131
Publication URI: http://europepmc.org/abstract/MED/34712131
Type: Journal Article/Review
Volume: 12
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812